Research, News & Discoveries
-
Neil Osheroff elected Fellow of the Australia and New Zealand Association for Health Professional Educators
The only elected fellow outside of Oceania and Southeast Asia, Neil Osheroff brings four decades of medical education to the highly regarded health professional educator association ANZAHPE. Read MoreNov. 22, 2024
-
Mary Ann Liebert, Inc. and Heard Libraries establish read-and-publish agreement in support of open science
A new open access agreement between Mary Ann Liebert, Inc. and the Heard Libraries—the first of its kind that a North American institution has signed with the publisher—expands opportunities for Vanderbilt authors to publish their research in leading science journals. Mary Ann Liebert, Inc. publishes of more than 100 peer-reviewed academic journals. Read MoreNov. 21, 2024
-
Ken Lau and Eunyoung Choi named 2024 Stanley Cohen Innovation Fund awardees
Eunyoung Choi and Ken Lau receive funding for novel cancer research, which may ultimately result in cancer detection and treatment options for patients. The fund supports early-stage, high-risk high-reward research projects and honor Cohen’s seminal discoveries, which led to the invention of many anticancer drugs used today. Read MoreNov. 21, 2024
-
Leigh Anne Tang wins 2024 Brighter Ventures Award
Leigh Anne Tang won the 2024 Brighter Ventures Award for her efforts to leverage health care artificial intelligence to influence the overdose crisis. She is the first Ph.D. student at Vanderbilt to work with the state on this type of translational research. Read MoreNov. 21, 2024
-
Vanderbilt building molecular atlas of colorectal cancer across different stages of disease onset with $5 million National Cancer Institute grant
Colorectal cancer is the second leading cause of cancer-related deaths in the U.S. Ken Lau and Jeffrey Spraggins are creating the first spatially mapped atlas characterizing the progression trajectories of early-onset colorectal cancer versus average-onset CRC as they transition from precancerous lesions to malignant cancers. Read MoreNov. 20, 2024
-
Eleven Vanderbilt scientists among world’s “highly cited” researchers
The Highly Cited Researchers list recognizes both the scientific achievements of individual scientists and “their profound impact on tackling broader societal challenges,” said Emmanuel Thiveaud, PhD, senior vice president for Research and Analytics at Clarivate. Read MoreNov. 19, 2024
-
Center for Extracellular Vesicle Research hosts annual retreat
The Center for Extracellular Vesicle Research, which is made up of over 20 laboratories spanning Vanderbilt University, held its annual retreat in late September. Researchers discussed the types of biomolecular cargoes EVs contain and how EVs holding unique cargoes can be used as diagnostic tools. Read MoreNov. 19, 2024
-
Looking in all directions: Exploring a new horizon for PCOS therapeutics
Polycystic ovarian syndrome is a complex endocrinological disorder with widespread prevalence, affecting approximately one in ten women worldwide. Treatment for PCOS typically involves extensive lifestyle modification and medications to help manage reproductive symptoms and insulin resistance, but there are no treatments that directly target hyperandrogenism. Because of this, women with PCOS often feel unsatisfied with the quality of their care and are belabored by the changes necessary to live out their daily lives. Read MoreNov. 18, 2024
-
Prashant Singh wins Research Excellence Award at 2024 Fall Staff Assembly
This award recognizes a staff member whose support of research has made a significant impact on the process of discovery and the pursuit of knowledge at Vanderbilt. This year’s winner of the award was Prashant Singh, a scientist and senior research associate in the department of pharmacology. Read MoreNov. 18, 2024
-
Olivia Kelly named 2024 JKL Wellness Fund awardee
Olivia Kelly, a Ph.D. student in the Heidi Hamm lab, received an award to study non-drug-based interventions for maintaining or restoring wellness to prevent Alzheimer’s disease. Read MoreNov. 14, 2024